Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. [electronic resource]
Producer: 20090724Description: 329-36 p. digitalISSN:- 1573-7373
- Adult
- Aged
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Phytogenic -- adverse effects
- Bevacizumab
- Brain Neoplasms -- drug therapy
- Camptothecin -- adverse effects
- Disease-Free Survival
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Glioma -- drug therapy
- Humans
- Irinotecan
- Magnetic Resonance Imaging -- methods
- Male
- Middle Aged
- Retrospective Studies
- Survival Analysis
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.